PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 18: Articles 8501-9000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Audit of patients' knowledge of their oral contraceptive pill.
  2. Aymara market women discuss risks of unwanted pregnancy and use of family planning services.
  3. The balance between food and people has become threatened. "State of World" report calls for more reliance on family planning than farming.
  4. The Bangladesh family planning program: key programmatic challenges and priority action areas. Draft.
  5. Bangladesh journalists. Reporting on population and family planning. Study results.
  6. Bangladesh: the National Family Planning Program. Public sector. Comprehensive service delivery systems.
  7. Barbados: Caribbean Contraceptive Social Marketing Project.
  8. Barrier contraceptives: current status and future prospects.
  9. Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.
  10. Bataenos' voice on family planning.
  11. Behavior Change Strategies for Family Planning [letter]
  12. Behavioural and social issues in contraception.
  13. Benefits and risks of combined oral contraceptives.
  14. Beyond Cairo: men, family planning, and reproductive health.
  15. Birth control for new parents.
  16. Birth control in Japan: realities and prognosis.
  17. Birth control in rural areas. [Regulacja urodzen w srodowisku wiejskim.]
  18. Birth control over 30.
  19. Birth control policies: an interview with Professor Michel Schooyans, University of Louvain, Belgium.
  20. Birth control politics in the United States, 1916-1945.
  21. Birth control, abortion are tough issues.
  22. Birth control, family planning or responsible parenthood? [Control de natalidad, planificacion familiar o paternidad responsable?]
  23. Birth of a nation: family planning in Albania.
  24. Black South African freshmen's experience of first coitus and contraception.
  25. Blood pressure changes and hormonal contraceptives.
  26. Blood, fecundity, and contraceptive usage. [Sangre, fertilidad y practicas anticonceptivas.]
  27. Bone mineral density and history of oral contraceptive use.
  28. A booster for contraceptive vaccines.
  29. Botswana males and family planning: surveys on households and institutions, 1990-1991.
  30. Brazil: HIV / STD prevention and family planning.
  31. Breakage and slippage of condoms in family planning clients.
  32. Breast cancer among young U.S. women in relation to oral contraceptive use.
  33. Breast cancer risk with oral contraceptives and oestrogen replacement therapy.
  34. Breast feeding is a natural contraceptive and prevents disease and death in infants, linking infant mortality and birth rates.
  35. Breastfeeding and family planning: mutual goals, vital decisions. [Videotape]
  36. Breastfeeding as a Women's Issue: A Dialogue on Health, Family Planning, Work, and Feminism, Washington, DC, September 13, 1993. Introduction.
  37. Breastfeeding in family planning programs: a help or a hindrance?
  38. Breastfeeding, contraceptive use, and fertility in Zimbabwe: a further analysis of the Demographic and Health Survey.
  39. Breastfeeding, lactational amenorrhea method, and natural family planning interface. Teaching guide.
  40. A brief history of population control and contraception.
  41. Briefing book. Family planning in Uttar Pradesh: a review of secondary research focused on contraceptive social marketing.
  42. Broadening contraceptive choice: lessons from Egypt.
  43. Carbohydrate metabolism studies after one year of using an oral contraceptive containing gestodene and ethinyl estradiol.
  44. Cardiac and neurologic complications in malignant hypertension due to oral contraceptive use.
  45. Catholics and contraception: a struggle for control.
  46. Cervical mucus examination alone is an unreliable family planning method. [Familienplanung allein durch Zervixschleimbeobachtung zu unsicher.]
  47. The challenges ahead: implications of STDs / AIDS for contraceptive research.
  48. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
  49. Changes in the demography in China. Part 1: social issues regarding family planning. [Valtozasok Kinaban a demografia tukreben. I. Csaladtervezessel osszefuggo tarsadalmi kerdesek.]
  50. The changing image of contraceptives in Cameroon: impact of a multi media campaign.
  51. Changing the attitudes and behavior of African men towards contraception: myths, facts, obstacles and opportunities.
  52. Characteristics associated with contraceptive use among adolescent females in school-based family planning programs.
  53. Characteristics of women receiving family planning services at Title X clinics -- United States, 1991.
  54. Charging the vas deferens -- a novel male contraceptive method.
  55. China's family planning program: how, and how well, did it work?
  56. China's family planning program: inputs and outcomes.
  57. Chinese monthly oral contraceptive [letter]
  58. Chlamydia trachomatis: prevalence and risk factors in a family planning setting [letter]
  59. Chlamydial serologic characteristics among intrauterine contraceptive device users: does copper inhibit chlamydial infection in the female genital tract?
  60. Choice of contraceptive modality by women in Norway.
  61. Choices and changes in contraceptive behaviour; the role of information sources.
  62. Choices in contraception [editorial]
  63. Choosing a contraceptive. What's best for you?
  64. Choosing a contraceptive: considerations for youth. [Wallchart]
  65. A church-state issue in Italy: doctors' role in birth control.
  66. Cigarette smoking and parity as risk factors for the development of symptomatic gall bladder disease in women: results of the Royal College of General Practitioners' oral contraception study.
  67. Client satisfaction. An interview with Dr. Moshira El Shaffie, undersecretary for family planning, Ministry of Health.
  68. Clients' perspectives on contraceptive technology and practices in the Tashkent region of Uzbekistan. A report of focus group research findings.
  69. Clients' perspectives on contraceptive technology and practices in three Central Asian republics: a report of focus group research findings.
  70. Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.
  71. Clinical experience with a triphasic oral contraceptive in healthy, nonsmoking women aged 35 to 45 years: results of a multicenter trial.
  72. A clinical trial with the monophasic contraceptive Marvelon. [Klinichen opit s monofazen kontratseptiv -- Marvelon.]
  73. Clinical usefulness of low-dose oral contraceptives for the treatment of adolescent hyperandrogenemia.
  74. Coagulation and anticoagulation effects of contraceptive steroids.
  75. Cognitive development, egocentrism, self-esteem, and adolescent contraceptive knowledge, attitudes, and behavior.
  76. Collaboration between Bangladesh and Indonesia in the field of family planning 1980-1993.
  77. Combination oral contraceptives.
  78. Combined oral contraceptive pills: a brief review.
  79. Combined use of condoms with other contraceptive methods among inner-city Baltimore women.
  80. Comments on "Contraceptive Methods Choice in Pakistan: Determined or Predetermined".
  81. Commercial family planning for India.
  82. Communicating population and family planning information to policymakers.
  83. Communication and family planning in Sub-Saharan Africa.
  84. Communication and overpopulation in Sub-Saharan Africa: analysis of family planning posters. [Communication et surpopulation en Afrique subsaharienne: analyse d'affiches sur la planification familiale.]
  85. Communication for change: translating family planning into a people's programme. Briefing document, IEC Strategy Development Workshop, October 6-7, 1994.
  86. Community based distribution of family planning in Africa: lessons from operations research.
  87. A community study of child spacing, fertility and contraception in West Pokot District, Kenya.
  88. A community study on contraceptive gap in periurban women of South Delhi.
  89. Comparative contraceptive efficacy of the female condom and other barrier methods.
  90. Comparative in vitro study of contraceptive agents with anti-HIV activity: gramicidin, nonoxynol-9, and gossypol.
  91. A comparative study of users of long-term contraceptive subdermal implants and female surgical contraception in Kenya.
  92. A comparison of efficiency of birth control input between China and India.
  93. A comparison of the effects of two monophasic low dose oral contraceptives on the inhibition of ovulation.
  94. Condom use relative to knowledge of sexually transmitted disease prevention, method of birth control, and past or present infection.
  95. Condoms, IUDs, counseling and natural family planning [letter]
  96. Condoms, IUDs, counseling and natural family planning [letter]
  97. Condoms, IUDs, counseling and natural family planning [letter]
  98. Condoms, IUDs, counseling and natural family planning [letter]
  99. Condoms, IUDs, counseling and natural family planning [letter]
  100. Consensus paper. Low dose contraceptive formulations: is further reduction in steroid dosage justified?
  101. Considerations of the working group on contraception and HIV.
  102. Constitutions of the world. Explicit references to family planning.
  103. Constructing natural fertility: the use of Western contraceptive technologies in rural Gambia.
  104. Contact factors in plasma from women on oral contraception -- significance of factor XI for the measured activity of factor XII.
  105. Continuation and discontinuation of contraceptive use by method and reasons for drop-out in CSI project. Final report. Cairo Demographic Center (CDC), the Population Council, Asia and Near East Operations Research and Technical Assistance Project, Sub-Contract No. C.193.33A.
  106. Continuation of contraceptive use in Slovenia -- life-table analysis.
  107. Contraception after unprotected sex.
  108. Contraception among adolescents. [Kontratseptsiia pri adolestsenti.]
  109. Contraception and abortion at the threshold of the year 2000: comparing rich and poor countries. [Contraccezione e aborto alle soglie del 2000: paesi poveri e paesi ricchi a confronto.]
  110. Contraception and abortion in nineteenth-century America.
  111. Contraception and abortions: trends and prospects for the 1990s.
  112. Contraception and adolescents: highlights from a recent NASPAG conference.
  113. Contraception and cancer prevention.
  114. Contraception and HIV / STD infections.
  115. Contraception and sickle cell disease.
  116. Contraception and unwanted pregnancy. 139 cases. [Contraception et grossesses non desirees. A propos de 139 cas.]
  117. Contraception and women's health.
  118. Contraception at first sex: the effects of sex education.
  119. Contraception by the end of the 20th century -- the role of the voluntary organizations.
  120. Contraception by the end of the 20th century.
  121. Contraception following pregnancy. [Anticonceptie na een bevalling.]
  122. Contraception for adolescents. [Empfangnisverhutung in der Adoleszenz.]
  123. Contraception for patients with psychiatric or medical disorders.
  124. Contraception for the diabetic woman. [La contraccezione nella donna diabetica.]
  125. Contraception for women with congenital heart disease.
  126. Contraception in family planning. [Kontratseptsiia i planirovanii semi.]
  127. Contraception in the future. [La contraception du futur.]
  128. Contraception in the Netherlands: the low abortion rate explained.
  129. Contraception in the perimenopause. [Kontrazeption in der Pramenopause.]
  130. Contraception in type I diabetic women: a survey of 808 women of reproductive age. [Empfangnisverhutung bei Typ-I-Diabetikerinnen: eine Erhebung bei 808 Frauen im fertilen Alter.]
  131. Contraception in women over 40. [La contraception chez la femme de plus de 40 ans.]
  132. Contraception in women with intercurrent disease.
  133. Contraception issues and options.
  134. Contraception the natural way. Herbs have played role from ancient Greece to modern-day Appalachia.
  135. Contraception use among teenagers seeking abortion -- a survey from Grampian.
  136. Contraception, population and health [editorial]
  137. Contraception, STDs, and risk-taking behavior: highlights from a recent ARHP conference.
  138. Contraception.
  139. Contraception. [La contraception.]
  140. Contraception. Choice advice.
  141. Contraception. Risk cover.
  142. Contraception: a user's handbook.
  143. Contraceptive advertising in the United States.
  144. Contraceptive and condom use for the prevention of pregnancy, STDs, and AIDS: a transtheoretical approach.
  145. Contraceptive behavior among women applying for abortion. [Praeventionsmonster blandt abortsogende kvinder.]
  146. Contraceptive behaviour in women carrying an unwanted pregnancy.
  147. The contraceptive benefit of breastfeeding.
  148. Contraceptive commodity requirements in developing countries in the 1990s.
  149. Contraceptive controversy. Medicine: implant removals spark suit.
  150. Contraceptive development: what we can achieve.
  151. Contraceptive dilemmas.
  152. Contraceptive discovery: mandelic acid can be used as a spermicide.
  153. Contraceptive dynamics in Colombia: discontinuation of contraceptive methods, change, and failure rates. [La dinamica anticonceptiva en Colombia: discontinuacion del uso de metodos anticonceptivos, cambio y tasas de falla de los metodos.]
  154. Contraceptive efficacy and acceptability of the female condom.
  155. Contraceptive efficacy of barrier contraceptives.
  156. Contraceptive efficacy of the diaphragm and cervical caps used in conjunction with a spermicide -- a fresh look at the evidence.
  157. Contraceptive implant found safe, acceptable, among Chinese women.
  158. Contraceptive implants and teenage pregnancy [editorial]
  159. Contraceptive implants.
  160. Contraceptive implants.
  161. Contraceptive introduction and the management of choice: the role of Cyclofem in Indonesia.
  162. Contraceptive introduction reconsidered: a review and conceptual framework.
  163. Contraceptive method mix in Indonesia. An analysis of the fertility, health and programmatic implications of greater promotion of voluntary sterilization.
  164. Contraceptive method mix. Guidelines for policy and service delivery.
  165. Contraceptive methods and risk of pelvic endometriosis.
  166. Contraceptive methods and the transmission of HIV: implications for family planning.
  167. Contraceptive methods choice in Pakistan: determined or predetermined.
  168. Contraceptive methods go back to the basics.
  169. Contraceptive myths.
  170. Contraceptive options for teenagers.
  171. The contraceptive potential of fertilization: a physiological perspective.
  172. Contraceptive practice among women seeking legal abortion in Hartlepool.
  173. Contraceptive practices before conception and after the birth of a child with a chronic health problem.
  174. The contraceptive practices of women seeking termination of pregnancy in an Auckland clinic.
  175. Contraceptive Prevalence Survey, Jamaica 1993. Volume V: Summary of results by health region.
  176. Contraceptive Prevalence Survey, Jamaica, 1993. Executive summary: main findings of the survey.
  177. Contraceptive Prevalence Survey, Jamaica, 1993. Volume I: Administrative report.
  178. Contraceptive Prevalence Survey, Jamaica, 1993. Volume III. Sexual experience, contraceptive practice and fertility.
  179. Contraceptive problems in variegate porphyria.
  180. Contraceptive requirements and logistics management needs in the Philippines.
  181. Contraceptive requirements and logistics management needs in Turkey.
  182. Contraceptive requirements and logistics management needs in Viet Nam.
  183. Contraceptive research and development today: an overview.
  184. Contraceptive research and development today: injectables.
  185. Contraceptive research and development, 1984 to 1994: the road from Mexico City to Cairo and beyond.
  186. Contraceptive revolution.
  187. Contraceptive rings -- a user-controlled long-acting method for family planning.
  188. Contraceptive safety and effectiveness: re-evaluating women's needs and professional criteria.
  189. Contraceptive self-efficacy in adolescents: testing the French version of the Levinson scale as applied to both males and females. [L'auto-efficacite relative a la contraception chez les adolescentes et les adolescents: la validation de la version francaise de l'echelle de mesure de Levinson.]
  190. Contraceptive side effects: responding to clients' concerns.
  191. Contraceptive social marketing in the Philippines. A new initiative.
  192. Contraceptive social marketing: pros and cons.
  193. Contraceptive strategies for the future.
  194. Contraceptive technology. 16th revised edition.
  195. Contraceptive use among women smokers and nonsmokers in the San Francisco Bay Area.
  196. Contraceptive use and attitudes among U.S. women.
  197. Contraceptive use and attitudes in reunified Germany.
  198. Contraceptive use and commodity costs in developing countries, 1994-2005.
  199. Contraceptive use and repeat pregnancies among welfare-dependent teenage mothers.
  200. Contraceptive use and the quality, price, and availability of family planning in Nigeria.
  201. Contraceptive use during lactational amenorrhea: estimates of double coverage among postpartum women using DHS I and II data.
  202. Contraceptive use during lactational amenorrhea: estimates of double coverage among postpartum women using DHSI and II data.
  203. Contraceptive use dynamics in Paraguay: an analysis of discontinuation, failure, and method change using life tables. Prepared for the Seminar on Contraceptive Dynamics in Latin America. [La dinamica del uso de la anticoncepcion en Paraguay: un analisis de discontinuacion, falla, y cambio de metodos con tablas de vida. Seminario sobre la Dinamica Anticonceptiva en America Latina.]
  204. Contraceptive use in Nicaragua and Jamaica.
  205. Contraceptive use in the United States: past, present and future.
  206. Contraceptive use. Audience analysis of women, men and providers knowledge, attitudes and practices in rural Vietnam.
  207. Contraceptive vaccine development.
  208. Contraceptive vaccines.
  209. Contraceptive vaccines.
  210. Contraceptive vaccines. Birth-control vaccine feasible, but more work needed.
  211. Contraceptives airlifted to Bosnia.
  212. Contraceptives and HIV. Editorial review.
  213. Contraceptives of the future in the light of HIV infection.
  214. Contraceptives. Case for public enquiry.
  215. Contraceptives: choice for the millions?
  216. The contributions of Mexican scientists to contraceptive research and development. [Aportes de los científicos mexicanos a la investigación y el desarrollo de métodos anticonceptivos.]
  217. Copper levels and reactive oxygen species in uterine flushings in copper intrauterine contraceptive device users.
  218. Cost analysis of Family Planning Services in Private Family Planning Programs, FEMAP, Mexico. Final report. Contract Number CI92.61A with the Federacion Mexicana de Asociaciones de Planificacion Familiar, FEMAP, Mexico, October 1, 1992 - February 28, 1994. Funded under Contract AID/DPE-3030-Z-00-9019-00 to the Population Council, INOPAL II.
  219. A cost-benefit analysis of four hormonal contraceptive methods.
  220. The cost-benefit study of family planning in Egypt. Summary report.
  221. Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
  222. Cost-effectiveness of the family planning programme in Pakistan.
  223. Counselling on contraceptive use strengthened in Dominican Republic.
  224. Credit programs, women's empowerment, and contraceptive use in rural Bangladesh.
  225. Critical reflections on clinical trials of contraceptives.
  226. Current experiences with community-based distribution of family planning in Kenya: a review prepared for USAID / Kenya.
  227. Current status of contraceptive research and development.
  228. Current status of estroprogestational contraception. [Le point actuel sur la contraception estroprogestative.]
  229. Current status of natural family planning in Granada (Spain)
  230. Cycle control and side effects of a new combiphasic oral contraceptive regimen.
  231. Cytopathologic changes associated with intrauterine contraceptive devices. A review of cervico-vaginal smears in 350 women.
  232. A decade of change in contraceptive behaviour in Latin America: a multivariate decomposition analysis.
  233. Decentralization of population and family planning programs: the case of anglophone Africa.
  234. Decision trees to guide post-abortion family planning counseling -- alternative approaches determined by women's abortion history.
  235. Declaration from the World Medical Association, 1994: Women's right to contraception and physicians' regulations in organ transplantation. [Deklarationer fran World Medical Association 1994. Kvinnors ratt till kontraception och lakarregler vid organtransplantationer.]
  236. Decline in fertility among Japanese women attributed not to contraceptive use but to late age at marriage.
  237. Delivery of family planning services in rural communities in Egypt: developing a representative picture from DHS surveys.
  238. Demographic aging and family planning: what relationship. [Envelhecimento demografico e planeamento familiar: que relacao?]
  239. Demographic change and family planning in Taiwan.
  240. Demographic changes in China Part 2: the "Chinese model" of family planning -birth control--healthy family. [Valtozasok Kinaban a demografia tukreben. II. A csalad--csaladtervezes--szuletesszabalyozas "kinai modellje".]
  241. Depo-Provera -- an injectable contraceptive.
  242. Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease.
  243. The detection of adducts in human cervix tissue DNA using 32P-postlabelling: a study of the relationship with smoking history and oral contraceptive use.

     

  244. Determinants of contraceptive choice in India.
  245. Determinants of contraceptive use in Egypt (1991)
  246. Determinants of contraceptive use in Kerala: the case of son / daughter preference.
  247. Determinants of family planning acceptance in rural Bihar.
  248. Determinants of inconsistent use of coitus-dependent contraceptives among U.S. women: 1990.
  249. The determinants of the duration of contraceptive use in China: an illustrative analysis of multinomial multilevel discrete hazards modelling.
  250. Determining an appropriate contraceptive method mix. OPTIONS II tool: Policy and programmatic use of DHS data analysis chapter. [Draft]
  251. The development of contraceptive technologies: a feminist critique.
  252. Development of male contraceptives.
  253. Developmental trends for oral contraceptives.
  254. Dexamethasone suppression test during pregnancy and contraception use. [Dexamethason-Suppressionstest in der Schwangerschaft und unter Ovulationshemmern.]
  255. A diagnostic study of the implementation of the Department of Health training course for family planning providers in Region II and Cordillera Administrative Region.
  256. Differential acceptance of family planning methods in a high performance district in Karnataka.
  257. Directory of training courses in family planning and reproductive health, 1994-95 edition.
  258. Discontinuing contraception. On research into determining factors. [Abandons de la contraception. A la recherche des facteurs determinants.]
  259. Disease at first pelvic exam of teens seeking contraception.
  260. DKT-backed oral contraceptives move ahead in India.
  261. Do interventions diminish differences in child mortality by mother's education? The case of maternal and child health-family planning project in Matlab.
  262. Does previous oral contraceptive use affect breast cancer survival? [Beeinflusst die vorangegangene Einnahme oraler Kontrazeptiva das Uberleben beim Mammakarzinom?]
  263. Doppler study of the uterine artery in patients using an intrauterine contraceptive device.
  264. Dr. Dupont integrates MCH and family planning services in Munda district. Case scenarios for training and group discussion.
  265. Dream contraceptive's nightmare.
  266. Each to her own: investigating women's response to contraception.
  267. Early oral contraceptive history: norethynodrel is not a prohormone [letter]
  268. The effect of family planning program on fertility in Egypt (1980-1991)
  269. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
  270. The effect of oral contraceptives on protein metabolism.
  271. Effect of oral contraceptives on the proliferative activity of breast cancer. [Der Einfuss oraler Kontrazeptiva auf die Proliferationsaktivitat de Mammakarzinoms.]
  272. The effect of patterns of oral contraceptive use on breast cancer risk in young women.
  273. The effect of previous oral contraceptive use on bone mineral density in perimenopausal women.
  274. The effect of price increases on contraceptive sales in Bangladesh.
  275. The effect of quality of care on contraceptive efficacy.
  276. The effect of sex preference on contraceptive use and fertility in rural south India.
  277. The effect of sex preference on contraceptive use and fertility in rural south India.
  278. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
  279. The effect of user fees on the utilization of family planning services. A clinical study.
  280. Effects of oral contraceptives on glucose metabolism.
  281. Effort and achievement in national family planning programmes.
  282. The Egyptian family planning success story.
  283. Emergency contraception.
  284. Emergency contraception.
  285. Emergency contraception.
  286. Emergency contraception: a review.
  287. The emergency contraceptive pill: an inquiry on knowledge and attitudes.
  288. Emergency contraceptive pills (ECP) protocol.
  289. Emergency postcoital contraception.
  290. Employment and the use of birth control by sexually active single Hispanic, black, and white women.
  291. Empowerment and family planning in Bangladesh.
  292. Enhancing the private sector's role in contraceptive research and development.
  293. The Enterprise Program follow-up study: were private sector family planning services sustained?
  294. Epidemiology of unintended pregnancy and contraceptive use.
  295. Erythrocyte folate levels, oral contraceptive use and abnormal cervical cytology.
  296. Estimates of contraceptive prevalence based on service statistics and surveys in Gujarat State, India.
  297. Estimation of continuation function of contraceptive use in Egypt, 1988.
  298. Estimation of contraceptive prevalence rate in Egypt (1991-2011)
  299. The estimation of potential demand for contraception and the implication for fertility in Uganda.
  300. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
  301. Evaluation of a family planning program for individuals with mental retardation.
  302. An evaluation of COPE, a family planning clinic self-assessment technique. Final report.
  303. Evaluation of family planning logistics management training in Bangladesh.
  304. Evaluation of the effect of a sex education program on knowledge, sexual behavior and contraception in adolescents. [Evaluacion de un programa de educacion sexual sobre conocimientos, conducta sexual y anticoncepcion en adolescentes.]
  305. Evaluation of the Family Planning Logistics Management II (FPLM II) Project (936-3038)
  306. Evaluation of the Family Planning Management Development Project (FPMD I) (936-3055)
  307. Evaluation of the medical barriers to family planning programs. [Evaluacion de las barreras medicas a los programas de planificacion familiar.]
  308. Evaluation of the Zimbabwe Family Planning Project (613-0230)
  309. The EVALUATION Project promotes consensus on family planning quality indicators.
  310. Evaluation report: quality of family planning services.
  311. Ever since Eve -- birth control in the ancient world.
  312. Executive summary. From contraceptive technology to reproductive health.
  313. Existing once-a-month combined injectable contraceptives.
  314. Expanded clinical trial of the Norplant contraceptive subdermal implants in Bangladesh.
  315. Expanding contraceptive choice and access: a dairy cooperative project in Bihar, India.
  316. Expanding contraceptive choice: the Norplant experience.
  317. Expanding family planning options through the systematic introduction and appropriate management of contraceptive methods.
  318. Expert Committee on Maternal and Child Health and Family Planning in the 1990s and Beyond: recent trends and advances, World Health Organization, Geneva 7-13, December 1993.
  319. Factors affecting the family planning program drop-out rates of Bukidnon.
  320. Factors inhibiting the use of reversible contraceptive methods in rural south India.
  321. Factors that contribute to the varying performance of BSPOs and BHWs in the delivery of family planning services in Iloilo City, Philippines. Final report: Subcontract Number C193.43A. Social Science Research Institute, Central Philippine University, The Population Council, Asia and Near East Operations Research and Technical Assistance Project.
  322. Facts about injectable contraception.
  323. Family planning [letter]
  324. Family planning agencies: services, policies and funding.
  325. Family planning and AIDS on Yokohama agenda.
  326. Family planning and contraceptive use in Iran, 1967-1992.
  327. Family planning and development.
  328. Family planning and gender issues among adolescents. Draft.
  329. Family planning and Guatemala's apartheid.
  330. Family planning and health. [Planification familiale et sante.]
  331. Family planning and induced abortion in the post Soviet Russia of the early 1990's: the unmet needs in information supply.
  332. Family planning and management of HIV / AIDS.
  333. Family planning and reproductive health -- a global overview.
  334. Family planning and reproductive health in developmenta cooperation.
  335. Family planning and reproductive health services in Ghana: an annotated bibliography.
  336. Family planning and reproductive health: briefing sheets for a gender analysis.
  337. Family planning and reproductive health: overview and vision.
  338. Family planning and status of women in Indonesia.
  339. Family planning and STDs / HIV.
  340. Family planning and sustainable development in Egypt.
  341. Family planning and the Malawian male.
  342. Family planning and tradition: a view from northern Cameroon.
  343. Family planning and welfare in northern Ghana.
  344. Family planning as a health instrument: its repercussion in poor rural and urban areas. [La planificacion familiar como un instrumento de salud: su repercusion en zona rural y urbana marginada.]
  345. Family planning at the cost of women's health?
  346. Family planning at the turn of the 21st century. [La planificacion familiar al filo del siglo XXI.]
  347. Family planning campaigns the best opportunity for AIDS advice.
  348. Family planning center opens in Moscow.
  349. Family planning clinics: current status and recent changes in services, clients, staffing, and income sources.
  350. Family planning counseling training: lessons learned and challenges.
  351. Family planning course workshop format. Module 1: Family planning and MCH and an overview of FP methods.
  352. Family planning course workshop format. Module 2: Counseling for FP services.
  353. Family planning course workshop format. Module 3: The oral contraceptive pill.
  354. Family planning course workshop format. Module 4: Voluntary surgical contraception.
  355. Family planning course workshop format. Module 5: The lactational amenorrhea method and condoms.
  356. Family planning course workshop format. Module 6: Progestin-only contraceptives: DMPA and a review of Norplant.
  357. Family planning course workshop format. Module 7: Human acquired immunodeficiency syndrome (AIDS): an update.
  358. Family planning course workshop format. Module 8: Intrauterine contraceptive devices: an overview.
  359. Family planning course workshop format. Module 9: Intrauterine contraceptive devices: providing services.
  360. Family planning decisions after prenatal detection of fetal abnormalities.
  361. Family planning demand fulfillment: the Indonesia experience.
  362. Family planning for healthy nations [editorial]
  363. Family planning gains ground even as comprehensive health care reform effort falters.
  364. Family planning in Central Asia: views of health professionals.
  365. Family planning in Georgia: a continuing struggle.
  366. Family planning in Jamshedpur.
  367. Family planning in Kenya: experiences and challenges.
  368. Family planning in Latin America: development, costs, and future. [La planificacion familiar en America Latina: desarrollo, costo, y futuro.]
  369. Family planning in Mexico. Investing in the social system. [Familienplanung in Mexiko. Investition in das Sozialsystem.]
  370. Family planning in Nepal: an update.
  371. Family planning in Nigeria: not yet uhuru.
  372. Family planning in Russia: a survey of 268 Russian women.
  373. Family planning in Sub-Saharan Africa.
  374. Family planning in sub-Saharan Africa: a case for market-based health and family planning project.
  375. Family planning in Uttar Pradesh: a review of secondary research focussed on contraceptive social marketing.
  376. Family planning in Viet Nam: a vigorous approach.
  377. Family planning investing in the future [editorial]
  378. Family planning knowledge and practice in Vietnam: results from a microlevel survey.
  379. Family planning knowledge, interest and information needs of district officials in Uttar Pradesh.
  380. A family planning library manual. Fifth revised and expanded edition.
  381. Family planning needs of male chronic mental patients in the general hospital psychiatry clinic.
  382. The Family Planning Operations Research and Training (FPORT) Program.
  383. Family planning or population control?
  384. A family planning paradigm.
  385. Family planning performance in Bihar.
  386. Family planning program and reproductive freedom in Yucatan, Mexico. [Programme de planification familiale et liberté reproductive au Yucatan, Mexique.]
  387. Family planning program in Indonesia.
  388. Family planning programmes in Uttar Pradesh. Issues for strategy development. Tables.
  389. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 1: Population and family planning studies.
  390. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 2: Health studies.
  391. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 3: Education studies.
  392. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 4: Women studies.
  393. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 5: Rural studies.
  394. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 6: Rural development studies.
  395. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 7: Urban studies.
  396. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 8: Organised sector studies.
  397. Family planning programmes in Uttar Pradesh: issues for strategy development. Abstract series 9: Political studies.
  398. Family planning programs and fertility transition in Sub-Saharan Africa.
  399. Family planning provides key to population policy.
  400. Family planning reduces mortality.
  401. Family planning services utilization increases for migrant workers. [Utilisation accrue des services de planification familiale par les travailleurs migrants.]
  402. Family planning status in Mexico. Contraception indicators. [Situacion de la planificacion familiar en Mexico. Indicadores de anticoncepcion.]
  403. Family planning studies in the Philippines: a review and synthesis. Philippines.
  404. Family planning success stories: Asia, Latin America, Africa.
  405. Family planning targets in relation to fertility reduction and reproductive health care in ECA member states.
  406. The family planning users' perspective.
  407. Family planning, STD services fare well under Kennedy health reform proposal. But abortion debate yet to come.
  408. Family planning.

     

  409. Family planning. [Planification familiale.]
  410. Family planning. [Planification familiale.]
  411. Family planning. [Planification familiale.]
  412. Family planning. Adults only?
  413. Family planning. Priority on family health in order to reach men. [Planification familiale. Priorite a la sante familiale pour toucher les hommes.]
  414. Family planning. Regional differences in contraceptive practice. [Planificacion familiar. Diferencias regionales en la practica anticonceptiva.]
  415. Family planning: a basic development need.
  416. Family planning: a development success story.
  417. Family planning: always in transition. IPPF / WHR reports: executive directors.
  418. Family planning: the key to a better future. [Planificacion familiar: la llave de un futuro mejor.]
  419. Female adolescents at the crossroads: sexuality, contraception and abortion.
  420. Fertility and family planning in African cities: the impact of female migration.
  421. Fertility and family planning in Fiji.
  422. Fertility and family planning in Mali. [Fecondite et planification familiale au Mali.]
  423. Fertility decline and demand for family planning in Kenya.
  424. Fertility-mortality variations across LDCs: women's education, labor force participation, and contraceptive-use.
  425. Final project report: Family Planning Training and Communication Project sub-agreement between the Johns Hopkins University and the Ministry of Public Health in Morocco, June 1, 1990 - July 31, 1992, NE-MOR-04.
  426. Final report of an operations research project: "Redesigning Compensation and Other Administrative and Technical Systems to Improve the Quality of Care in Peruvian Family Planning Programs". Subcontracts CI90.89A and CI91.01A, November 15, 1990 - October 15, 1993.
  427. Final report of an operations research project: "Testing Pricing / Payment Systems to Improve Access and Cost-Recovery from Norplant", Subcontract CI92.09A. March 1, 1992 - February 28, 1994. Participating agencies: Asociacion Pro-Bienestar de la Familia Colombiana (PROFAMILIA), Population Council / INOPAL II, International Planned Parenthood Federation / Western Hemisphere Region (IPPF/WHR)
  428. Final report, the Population Council / Mexico, INOPAL II in-house project: Development of a Training Manual on Quality of Care Improvement in Family Planning Organizations. January 1, 1992 - November 30, 1993.
  429. Final report. Combining family planning activities with the Expanded Programme on Immunization. Rwanda Office National de la Population. Contract No. CI91.79A, November 1991 - October 1993. [Rapport final. Association des Activites de Planning Familial au Programme Elargi de Vaccinations. L'Office National de la Population (ONAPO), Rwanda. Contrat No. CI91.79A, Novembre 1991 - Octobre 1993.]
  430. Final report. Family Planning Mass Media Campaign Evaluation. JHU / PCS Project No.: AS-PAK-04, August 15, 1991 - September 30, 1992.
  431. Final report. Integration of family planning activities into the Expanded Programme on Immunization, Office National de la Population (ONAPO), Rwanda. Contract No. CI91.79A, November 1991 - October 1993. [Rapport final. Association des activites de planning familial au Programme Elargi de Vaccinations. L'Office National de la Population (ONAPO), Rwanda, Contrat No. CI91.79A, Novembre 1991 - Octobre 1993.]
  432. Final report. Perceptions of reproductive morbidity among Nigerian women and men: implications for family planning services. Institute for Child Health and Primary Care, College of Medicine, Lagos, Nigeria. Contract No. CI92.20A, May 1992 - November 1993.
  433. Final report. Workshop on Improvement of Village Based Family Planning Worker Training Standards, Rawalpindi, Pakistan, December 13-15, 1994.
  434. Final report. Workshop on Village Based Family Planning Worker Quality Improvement, Murree, Pakistan, October 17-19, 1994.
  435. Final report. Workshop on Village Based Family Planning Worker Quality Improvement, Quetta, Pakistan, November 21-23, 1994.
  436. Final report. Workshop on Village Based Family Planning Worker Quality Improvement, Rawalpindi, Pakistan, December 19-21, 1994.
  437. Final report. Workshop on Village Based Family Planning Worker Quality Improvement, Saidu Sharif, Pakistan, June 12-14, 1994.
  438. Final report: Information, Communication and Education (IEC) for Postpartum Family Planning and Breastfeeding Program. Subagreement between the Johns Hopkins University Population Communication Services and Comprehensive Family Planning Center at the Jose Fabella Memorial Hospital, February 1990 - July 1992, AS-PHI-07.
  439. Final report: Knowledge, Attitude and Practice on Family Planning (Project Bullseye 2)
  440. Final report: the El Salvador mass media family planning campaign. LA-ELS-01.
  441. Final technical report: The Use of Management Quality Systems to Institutionalize Operations Research in Family Planning Organizations (Sub-agreement No. CI91.11A), March 1, 1991 - June 30, 1994. [Participating institutions]: MEXFAM and the Population Council.
  442. Financing the future: meeting the demand for family planning. 1994 report on progress towards world population stabilization.
  443. First clinical experience with contraceptive implants in the UK [letter]
  444. First phase of a prospective effectiveness study of natural family planning (NFP) carried out in the French speaking part of Belgium. [Premiere phase d'une etude prospective d'efficacite du planning familial naturel realisee en Belgique francophone.]
  445. Flexible family planning. Xinjiang Uygur autonomous region.
  446. Focus-group research for family planning: lessons learned in Sub-Saharan Africa.
  447. The forecasting cookbook. A commodity forecasting and requirements estimation manual for family planning and AIDS / STD prevention programs. Draft.
  448. The forties -- aging? Contraception after age 40. [Quarantiemes...vieillissants? Contraception apres quarante ans.]
  449. Forty years of saving lives with family planning.
  450. Four perspectives of family planning.
  451. Free materials on family planning. [Materiales gratuitos sobre planificacion familiar.]
  452. Frequency of pregnancy in acne patients taking oral antibiotics and oral contraceptives [letter]
  453. From abortion to contraception. Coming to terms with sovereignty.
  454. From family planning and maternal and child health to reproductive health.
  455. From family planning to reproductive health.
  456. From menarche to menopause: the contraceptive transition.
  457. From Plato to Pius: the ethics of birth control.
  458. The fruits of birth control [editorial]
  459. Future contraceptive methods.
  460. Future directions for family planning operations research: towards a greater appreciation of psychosocial issues.
  461. Future goals and directions of family planning programmes: a case study of Taiwan.
  462. The Gambia: using radio to promote family planning.
  463. GAPS in family planning care [letter]
  464. Gender differences in media exposure and action during a family planning campaign in Ghana.
  465. Gender issues and the reassessment of unmet need in family planning.
  466. Getting men involved in family planning in Sub-Saharan Africa: the Zimbabwean experience.
  467. Ghana: the Registered Midwives Association Family Planning Services Project.
  468. Global perspectives on post-abortion family planning.
  469. Glossary of natural family planning terms. 2nd ed.
  470. GnRH antagonists and antiprogestins: novel contraceptive options.
  471. Gonadotropin releasing hormone analogues for contraception.
  472. Guidelines and instruments for a family planning situation analysis study. Draft.
  473. Guidelines for breastfeeding, family planning, and the lactational amenorrhea method. [Videotape]
  474. Guidelines in choosing a contraceptive pill [editorial]
  475. Guidelines: breastfeeding, family planning, and the lactational amenorrhea method-LAM.
  476. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
  477. Half of Nicaraguan women use contraceptives, yet birthrates remain high.
  478. Health aspects of the family planning program. [Zdravstveni aspekti programa za planiranje porodice.]
  479. The health rationale for family planning: timing of births and child survival.
  480. The health risks and benefits of contraceptive use.
  481. Health workers' guide to natural family planning.
  482. Helping patients make informed contraceptive decisions.
  483. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
  484. Hemostatic balance during treatment with the newest contraceptives. [Den haemostatiske balance under behandling med nyere p-pillepraeparater.]
  485. High doses of oral contraceptives do not alter endometrial alpha 1 and alpha v beta 3 integrins in the late implantation window.
  486. High school students' knowledge, attitude and practice of contraception in Harer town, eastern Ethiopia.
  487. The history of family planning among women who choose surgical sterilization in the Caja de Seguro Social of Panama. [Historia de la planificacion familiar en las mujeres que optan por la esterilizacion quirurgica en la Caja de Seguro Social de Panama.]
  488. History, scope and methodology of fertility and family planning surveys in South Africa.
  489. HIV risk assessment in family planning clinics in Brazil.
  490. Homestudy course in family planning. Module 10: Post-abortion care. Draft.
  491. Honduran women received no written information on contraceptive pill.
  492. Hormonal contraception. Current status and future perspectives.
  493. Hormonal implants: contraception for a new century.
  494. How attitudes toward family planning and discussion between wives and husbands affect contraceptive use in Ghana.
  495. How do contraceptive methods affect woman's sexuality? [Wie beeinflussen kontrazeptive Methoden die Sexualitat der Frau?]
  496. How economic development and family planning programs combined to reduce Indonesian fertility.
  497. How frequently is emergency contraception prescribed?
  498. How the contraceptive injection Depo-Provera has affected women.
  499. Human capital, family planning, and their effects on population growth.
  500. Husband's involvement boosts contraceptive use among Ethiopian couples.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.